A citation-based method for searching scientific literature

Wan-Chun Chang, Reo Tanoshima, Colin J D Ross, Bruce C Carleton. Annu Rev Pharmacol Toxicol 2021
Times Cited: 4







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.
Linda M Henricks, Carin A T C Lunenburg, Femke M de Man, Didier Meulendijks, Geert W J Frederix, Emma Kienhuis, Geert-Jan Creemers, Arnold Baars, Vincent O Dezentjé, Alexander L T Imholz,[...]. Lancet Oncol 2018
121
25



Nucleic Acid Quantitation with Log-Linear Response Hybridization Probe Sets.
Lucia R Wu, John Z Fang, Dmitriy Khodakov, David Yu Zhang. ACS Sens 2020
2
50

[Biochips--tools of 21st century medicine].
J Bürger. Versicherungsmedizin 2006
3
33


HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.
Marica Garziera, Ettore Bidoli, Erika Cecchin, Enrico Mini, Stefania Nobili, Sara Lonardi, Angela Buonadonna, Domenico Errante, Nicoletta Pella, Mario D'Andrea,[...]. PLoS One 2015
21
25

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
25

Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing.
K E Caudle, C F Thorn, T E Klein, J J Swen, H L McLeod, R B Diasio, M Schwab. Clin Pharmacol Ther 2013
227
25

Is this the real time for genomics?
Maria Guarnaccia, Giulia Gentile, Enrico Alessi, Claudio Schneider, Salvatore Petralia, Sebastiano Cavallaro. Genomics 2014
12
25


Very important pharmacogene summary: thiopurine S-methyltransferase.
Liewei Wang, Linda Pelleymounter, Richard Weinshilboum, Julie A Johnson, Joan M Hebert, Russ B Altman, Teri E Klein. Pharmacogenet Genomics 2010
26
25

The clinical relevance of multiple DPYD polymorphisms on patients candidate for fluoropyrimidine based-chemotherapy. An Italian case-control study.
Francesco Iachetta, Candida Bonelli, Alessandra Romagnani, Raffaella Zamponi, Lorenzo Tofani, Enrico Farnetti, Davide Nicoli, Angela Damato, Maria Banzi, Bruno Casali,[...]. Br J Cancer 2019
12
25

Genotyping of KRAS Mutational Status by the In-Check Lab-on-Chip Platform.
Maria Guarnaccia, Rosario Iemmolo, Floriana San Biagio, Enrico Alessi, Sebastiano Cavallaro. Sensors (Basel) 2018
3
33

Novel biochip platform for nucleic acid analysis.
Salvatore Pernagallo, Giorgio Ventimiglia, Claudia Cavalluzzo, Enrico Alessi, Hugh Ilyine, Mark Bradley, Juan J Diaz-Mochon. Sensors (Basel) 2012
18
25

Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.
Angela Roco, Luis Quiñones, José A G Agúndez, Elena García-Martín, Valentina Squicciarini, Carla Miranda, Joselyn Garay, Nancy Farfán, Iván Saavedra, Dante Cáceres,[...]. Front Genet 2012
42
25

A microarray-based detection system for genetically modified (GM) food ingredients.
Serge Leimanis, Marta Hernández, Sophie Fernández, Francine Boyer, Malcolm Burns, Shirin Bruderer, Thomas Glouden, Neil Harris, Othmar Kaeppeli, Patrick Philipp,[...]. Plant Mol Biol 2006
57
25

Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients.
Marie-Christine Etienne, Jean-Louis Formento, Maurice Chazal, Mireille Francoual, Nicolas Magné, Patricia Formento, André Bourgeon, Jean-François Seitz, Jean-Robert Delpero, Christian Letoublon,[...]. Pharmacogenetics 2004
111
25

Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice.
Mariamena Arbitrio, Francesca Scionti, Maria Teresa Di Martino, Daniele Caracciolo, Licia Pensabene, Pierfrancesco Tassone, Pierosandro Tagliaferri. Clin Transl Sci 2021
8
25

Pharmacogenomics and individualized drug therapy.
Michel Eichelbaum, Magnus Ingelman-Sundberg, William E Evans. Annu Rev Med 2006
367
25

Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.
Volker M Lauschke, Lili Milani, Magnus Ingelman-Sundberg. AAPS J 2017
64
25

Clinical application of pharmacogenetics.
B B Spear, M Heath-Chiozzi, J Huff. Trends Mol Med 2001
296
25

[Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].
J C Stingl, J Brockmöller. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013
3
33

Label-free graphene oxide-based SPR genosensor for the quantification of microRNA21.
Michael López Mujica, Yuanyuan Zhang, Féthi Bédioui, Fabiana Gutiérrez, Gustavo Rivas. Anal Bioanal Chem 2020
5
25

Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate.
P Chiusolo, G Reddiconto, I Casorelli, L Laurenti, F Sorà, L Mele, L Annino, G Leone, S Sica. Ann Oncol 2002
123
25

Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.
M V Relling, E E Gardner, W J Sandborn, K Schmiegelow, C-H Pui, S W Yee, C M Stein, M Carrillo, W E Evans, J K Hicks,[...]. Clin Pharmacol Ther 2013
227
25

Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency.
A B Van Kuilenburg, P Vreken, N G Abeling, H D Bakker, R Meinsma, H Van Lenthe, R A De Abreu, J A Smeitink, H Kayserili, M Y Apak,[...]. Hum Genet 1999
193
25

Drug development in oncology: classical cytotoxics and molecularly targeted agents.
Shivaani Kummar, Martin Gutierrez, James H Doroshow, Anthony J Murgo. Br J Clin Pharmacol 2006
96
25

Biosensors in Health Care: The Milestones Achieved in Their Development towards Lab-on-Chip-Analysis.
Suprava Patel, Rachita Nanda, Sibasish Sahoo, Eli Mohapatra. Biochem Res Int 2016
40
25

DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.
Marzia Del Re, Saverio Cinieri, Angela Michelucci, Stefano Salvadori, Fotios Loupakis, Marta Schirripa, Chiara Cremolini, Stefania Crucitta, Cecilia Barbara, Angelo Di Leo,[...]. Pharmacogenomics J 2019
20
25



Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
Tessa M Bosch, Irma Meijerman, Jos H Beijnen, Jan H M Schellens. Clin Pharmacokinet 2006
124
25

Genomics and drug response.
Liewei Wang, Howard L McLeod, Richard M Weinshilboum. N Engl J Med 2011
375
25

Sex Differences in the Inflammatory Response: Pharmacological Opportunities for Therapeutics for Coronary Artery Disease.
Asad Shabbir, Krishnaraj Sinhji Rathod, Rayomand Syrus Khambata, Amrita Ahluwalia. Annu Rev Pharmacol Toxicol 2021
5
25

Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy.
Adam S Darwich, Thomas M Polasek, Jeffrey K Aronson, Kayode Ogungbenro, Daniel F B Wright, Brahim Achour, Jean-Luc Reny, Youssef Daali, Birgit Eiermann, Jack Cook,[...]. Annu Rev Pharmacol Toxicol 2021
8
25

Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab.
Linda Bouhlel, Jérôme Doyen, Emmanuel Chamorey, Michel Poudenx, Marius Ilie, Jocelyn Gal, Joël Guigay, Jonathan Benzaquen, Charles-Hugo Marquette, Jean-Philippe Berthet,[...]. Bull Cancer 2020
5
25

Dicarbonyl-mediated AGEing and diabetic kidney disease.
Alexandra Dimitropoulos, Carlos J Rosado, Merlin C Thomas. J Nephrol 2020
5
25

Engineering the Microbiome to Prevent Adverse Events: Challenges and Opportunities.
Saad Khan, Ruth Hauptman, Libusha Kelly. Annu Rev Pharmacol Toxicol 2021
4
25

Hazard characterization of silver nanoparticles for human exposure routes.
Yingzhu Li, Enda Cummins. J Environ Sci Health A Tox Hazard Subst Environ Eng 2020
7
25

Mechanism of Action of TiO2: Recommendations to Reduce Uncertainties Related to Carcinogenic Potential.
Hedwig M Braakhuis, Ilse Gosens, Minne B Heringa, Agnes G Oomen, Rob J Vandebriel, Monique Groenewold, Flemming R Cassee. Annu Rev Pharmacol Toxicol 2021
10
25

Preventing and Treating Anthracycline Cardiotoxicity: New Insights.
Konrad Teodor Sawicki, Valentina Sala, Lorenzo Prever, Emilio Hirsch, Hossein Ardehali, Alessandra Ghigo. Annu Rev Pharmacol Toxicol 2021
6
25

Sex differences in bicuspid aortic valve disease.
William K F Kong, Jeroen J Bax, Hector I Michelena, Victoria Delgado. Prog Cardiovasc Dis 2020
3
33


A Serendipitous Path to Pharmacology.
Baldomero M Olivera. Annu Rev Pharmacol Toxicol 2021
1
100

Approaching Sex Differences in Cardiovascular Non-Coding RNA Research.
Amela Jusic, Antonio Salgado-Somoza, Ana B Paes, Francesca Maria Stefanizzi, Núria Martínez-Alarcón, Florence Pinet, Fabio Martelli, Yvan Devaux, Emma Louise Robinson, Susana Novella,[...]. Int J Mol Sci 2020
4
25

Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure.
Sarah Waliany, Daniel Lee, Ronald M Witteles, Joel W Neal, Patricia Nguyen, Mark M Davis, Joe-Elie Salem, Sean M Wu, Javid J Moslehi, Han Zhu. Annu Rev Pharmacol Toxicol 2021
8
25

Nanoparticle Toxicology.
Wen Yang, Lin Wang, Evan M Mettenbrink, Paul L DeAngelis, Stefan Wilhelm. Annu Rev Pharmacol Toxicol 2021
11
25

Toxicology and carcinogenesis studies of dietary titanium dioxide-coated mica in male and female Fischer 344 rats.
B K Bernard, M R Osheroff, A Hofmann, J H Mennear. J Toxicol Environ Health 1990
68
25

Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance.
Arthur Geraud, Paul Gougis, Aurore Vozy, Celine Anquetil, Yves Allenbach, Emanuela Romano, Elisa Funck-Brentano, Javid J Moslehi, Douglas B Johnson, Joe-Elie Salem. Annu Rev Pharmacol Toxicol 2021
13
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.